成大生物
(688739)
| 流通市值：107.57亿 | | | 总市值：107.57亿 |
| 流通股本：4.16亿 | | | 总股本：4.16亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 3,961,121,082.99 | 4,496,464,173.92 | 4,264,317,684.83 | 4,133,700,011.91 |
| 应收票据及应收账款 | 1,125,375,730.04 | 1,076,901,537.54 | 1,193,923,521.43 | 1,193,926,644.1 |
| 应收账款 | 1,125,375,730.04 | 1,076,901,537.54 | 1,193,923,521.43 | 1,193,926,644.1 |
| 预付款项 | 27,434,142.69 | 23,688,069.38 | 33,505,549.8 | 31,772,432.31 |
| 其他应收款合计 | 1,470,996.83 | 1,410,319.73 | 1,559,575.68 | 1,547,398.68 |
| 存货 | 445,146,367.44 | 459,942,981.39 | 447,853,539.1 | 435,659,834.75 |
| 其他流动资产 | 68,146,624.57 | 51,903,309.34 | 30,853,224.78 | 323,858.33 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 7,073,879,636.64 | 7,083,333,289.91 | 7,063,829,229.86 | 7,004,743,625.52 |
| 非流动资产: | | | | |
| 长期股权投资 | 56,932,058.2 | 56,896,560 | 104,147,251.69 | 108,470,884.15 |
| 其他非流动金融资产 | 75,478,021.07 | 75,478,021.07 | 95,103,711.08 | 95,103,711.08 |
| 固定资产 | 1,437,017,436.1 | 1,480,092,317.43 | 1,508,992,817.6 | 1,519,722,981.69 |
| 在建工程 | 506,935,671.64 | 465,579,320.09 | 408,674,041.58 | 392,249,634.62 |
| 使用权资产 | 14,052,190.2 | 15,278,021.61 | 16,503,853.02 | 17,729,684.43 |
| 无形资产 | 185,743,706.56 | 181,452,488.18 | 183,271,615.64 | 184,872,159.76 |
| 开发支出 | 609,663,201.03 | 574,698,171.48 | 514,867,903.95 | 459,412,363.55 |
| 长期待摊费用 | 12,807,514.61 | 13,842,078.74 | 14,876,642.87 | 15,911,207 |
| 递延所得税资产 | 41,054,299.19 | 35,717,812.05 | 39,866,835.11 | 37,247,813.34 |
| 其他非流动资产 | 67,059,680.94 | 69,219,185.75 | 83,197,497.1 | 95,930,241.48 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 3,006,743,779.54 | 2,968,253,976.4 | 2,969,502,169.64 | 2,926,650,681.1 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 10,080,623,416.18 | 10,051,587,266.31 | 10,033,331,399.5 | 9,931,394,306.62 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 267,107,833.69 | 252,021,553.48 | 258,576,454.34 | 257,092,783.93 |
| 应付账款 | 267,107,833.69 | 252,021,553.48 | 258,576,454.34 | 257,092,783.93 |
| 合同负债 | 390,439.45 | 3,648,092.15 | 865,256.29 | 4,739,806.23 |
| 应付职工薪酬 | 71,051,803.34 | 122,837,222.65 | 81,191,721.5 | 71,056,167.08 |
| 应交税费 | 7,404,663 | 8,800,252.87 | 32,633,293.61 | 39,994,285.49 |
| 其他应付款合计 | 2,145,801.23 | 858,900 | 977,800 | 863,800 |
| 应付股利 | 381,900 | 381,900 | 400,800 | 400,800 |
| 一年内到期的非流动负债 | 5,216,607.36 | 5,139,220.8 | 5,081,183.11 | 5,023,634.71 |
| 其他流动负债 | 986.68 | 1,515.35 | 1,788.79 | 7,511.04 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 353,318,134.75 | 393,306,757.3 | 379,327,497.64 | 378,777,988.48 |
| 非流动负债: | | | | |
| 租赁负债 | 9,482,718.36 | 10,002,268.69 | 12,217,378.31 | 12,512,721.55 |
| 递延收益 | 83,021,365.98 | 85,604,461.47 | 92,247,773.96 | 94,951,403.45 |
| 递延所得税负债 | 112,140.73 | 194,295.74 | 184,924.71 | 51,580.46 |
| 其他非流动负债 | 3,100 | 11,532 | 9,300 | 6,200 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 92,619,325.07 | 95,812,557.9 | 104,659,376.98 | 107,521,905.46 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 445,937,459.82 | 489,119,315.2 | 483,986,874.62 | 486,299,893.94 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 416,450,000 | 416,450,000 | 416,450,000 | 416,450,000 |
| 资本公积 | 5,034,174,119.54 | 5,034,174,119.54 | 5,034,174,119.54 | 5,034,174,119.54 |
| 减:库存股 | 149,992,850 | 149,992,850 | 149,992,850 | 144,758,144.13 |
| 盈余公积 | 208,225,000 | 208,225,000 | 208,225,000 | 208,225,000 |
| 未分配利润 | 4,125,829,686.82 | 4,053,611,681.57 | 4,040,488,255.34 | 3,931,003,437.27 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 9,634,685,956.36 | 9,562,467,951.11 | 9,549,344,524.88 | 9,445,094,412.68 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 9,634,685,956.36 | 9,562,467,951.11 | 9,549,344,524.88 | 9,445,094,412.68 |
| 负债和股东权益合计 | 10,080,623,416.18 | 10,051,587,266.31 | 10,033,331,399.5 | 9,931,394,306.62 |
| 公告日期 | 2025-04-30 | 2025-04-24 | 2024-10-30 | 2024-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |